Monogenetic Disorders Testing Market size is estimated to be USD 5.3 Billion in 2024 and is expected to reach USD 12.2 Billion by 2033 at a CAGR of 9.4% from 2026 to 2033.
The global Monogenetic Disorders Testing Market was valued at approximately USD 5.6 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of around 12.4% from 2022 to 2030. The rising prevalence of monogenetic disorders, including cystic fibrosis, sickle cell anemia, and thalassemia, is driving the demand for early diagnostic solutions. Increasing awareness and improved accessibility to genetic testing are further fueling market expansion. North America held the largest market share in 2022, accounting for over 40% of the global revenue. This dominance is attributed to advanced healthcare infrastructure, higher adoption rates of genetic testing, and favorable reimbursement policies. Europe followed closely, driven by increasing investments in precision medicine and genetic research. The Asia Pacific region is expected to exhibit the fastest growth rate over the forecast period, supported by rising healthcare expenditure and growing awareness about genetic disorders in countries such as China and India.
Opportunities in the Monogenetic Disorders Testing Market are expanding with technological advancements in next generation sequencing (NGS) and polymerase chain reaction (PCR) techniques, enhancing the accuracy and efficiency of genetic tests. The increasing trend of direct to consumer genetic testing is creating new revenue streams, particularly in developed regions. Additionally, government initiatives promoting genetic screening programs and newborn screening for inherited disorders are contributing to market growth. The expansion of personalized medicine and the growing demand for early disease diagnosis present lucrative opportunities for market players. Furthermore, collaborations between research institutes and diagnostic companies to develop novel testing solutions are expected to accelerate market expansion in the coming years.
Get | Download Sample Copy with TOC, Graphs & List of Figures @ http://verifiedmarketreports.com/download-sample/?rid=821020&utm_source=Pulse_G_May&utm_medium=235
Celera Group
Abbott
Thermo Fisher Scientific
ELITech Group
Quest
AutoGenomics
PerkinElmer
Roche
Bio-Rad
Transgenomic
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=821020&utm_source=Pulse_G_May&utm_medium=235
Growing demand for below applications around the world has had a direct impact on the growth of the Global Monogenetic Disorders Testing Market
Targeted Gene Panels
Whole Exome Sequencing (WES)
Whole Genome Sequencing (WGS)
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Cystic Fibrosis
Sickle Cell Disease
Huntington's Disease
Duchenne Muscular Dystrophy
Tay-Sachs Disease
Hospitals
Diagnostic Laboratories
Research Institutions
Home Healthcare
Pharmaceutical Companies
Blood Samples
Saliva Samples
Tissue Biopsies
Amniotic Fluid
Chorionic Villus Sampling (CVS)
Newborn Screening
Carrier Screening
Preconception Testing
Diagnostic Testing
Prenatal Testing
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ https://www.verifiedmarketreports.com/product/monogenetic-disorders-testing-market/
1. Introduction of the Global Monogenetic Disorders Testing Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Monogenetic Disorders Testing Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Monogenetic Disorders Testing Market, By Type
6. Global Monogenetic Disorders Testing Market, By Application
7. Global Monogenetic Disorders Testing Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Global Monogenetic Disorders Testing Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/